Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXDX | AZN | AMGN | GILD | VRTX |
| Company | Prometheus Biosciences Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 199.68 | 90.37 | 329.09 | 120.98 | 455.65 |
| High | 199.98 | 90.41 | 329.67 | 122.20 | 457.17 |
| Low | 199.60 | 89.73 | 323.13 | 120.59 | 450.00 |
| Latest | 199.92 | 90.00 | 323.73 | 122.01 | 446.54 |
| Change | +0.18 | -0.18 | -6.16 | +0.79 | -8.94 |
| % Change | +0.09% | -0.20% | -1.87% | +0.65% | -1.96% |
| Volume | 1,860,600 | 997,897 | 369,980 | 775,924 | 108,257 |
| 20-Day Average Volume | 1,174,595 | 5,274,849 | 2,758,055 | 6,714,168 | 1,348,417 |
| Previous Close | 199.74 | 90.18 | 329.89 | 121.22 | 455.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 198.02 | 90.11 | 337.79 | 124.47 | 435.15 |
| 20-Day Raw Stochastic | 99.23% | 52.20% | 24.50% | 35.70% | 79.16% |
| 20-Day Relative Strength | 81.45 | 58.97 | 52.09 | 48.21 | 61.47 |
| Weighted Alpha | +110.70 | +38.42 | +21.90 | +29.02 | +1.87 |
| Today's Opinion | 100% Buy | 96% Buy | 80% Buy | 80% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.47% since 06/08/23 | -0.45% since 12/01/25 | -3.37% since 12/01/25 | -2.47% since 12/01/25 | +6.37% since 12/01/25 |
| Low | 198.91 on 06/09/23 | 89.77 on 12/04/25 | 324.88 on 12/08/25 | 120.38 on 12/05/25 | 424.06 on 12/02/25 |
| High | 199.98 on 06/15/23 | 91.28 on 12/03/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +2.82% since 05/15/23 | +6.54% since 11/07/25 | +1.85% since 11/07/25 | +2.04% since 11/07/25 | +10.56% since 11/07/25 |
| Low | 189.76 on 05/16/23 | 85.85 on 11/10/25 | 319.54 on 11/10/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 199.98 on 06/15/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +72.97% since 03/15/23 | +10.48% since 09/08/25 | +16.39% since 09/08/25 | +4.64% since 09/08/25 | +14.54% since 09/08/25 |
| Low | 104.55 on 03/30/23 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 199.98 on 06/15/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +85.68% since 12/15/22 | +23.64% since 06/06/25 | +12.33% since 06/06/25 | +7.83% since 06/06/25 | +0.50% since 06/06/25 |
| Low | 103.33 on 01/06/23 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 199.98 on 06/15/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,558,772 | 279,686,592 | 177,639,520 | 150,395,232 | 115,563,928 |
| Shares Outstanding, K | 47,813 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 6,810,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -141,750,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 1,110,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -40,880,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -0.49 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.86 on 05/09/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 08/10/23 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.70 | 15.55 | 14.97 | 29.87 |